Back to User profile » Dr Jeffrey Fudin
Papers published by Dr Jeffrey Fudin:
A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects
Gudin J, Argoff C, Fudin J, Greuber E, Vought K, Patel K, Nalamachu S
Journal of Pain Research 2020, 13:1485-1496
Published Date: 22 June 2020
A Randomized, Crossover, Pharmacokinetic and Adhesion Performance Study of a Lidocaine Topical System 1.8% During Physical Activity and Heat Treatment in Healthy Subjects
Fudin J, Wegrzyn EL, Greuber E, Vought K, Patel K, Nalamachu S
Journal of Pain Research 2020, 13:1359-1367
Published Date: 10 June 2020
Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions
Gudin J, Fudin J
Journal of Pain Research 2020, 13:447-456
Published Date: 25 February 2020
Fact or fiction: the truth behind the doctors company claims regarding licit and illicit opioids
Dragic LL, Fudin J, Schatman ME
Journal of Pain Research 2018, 11:2295-2299
Published Date: 11 October 2018
Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes
Dragic LL, Wegrzyn EL, Schatman ME, Fudin J
Journal of Pain Research 2018, 11:37-40
Published Date: 22 December 2017
Safety concerns with the Centers for Disease Control opioid calculator
Fudin J, Raouf M, Wegrzyn EL, Schatman ME
Journal of Pain Research 2018, 11:1-4
Published Date: 18 December 2017
Rational dosing of gabapentin and pregabalin in chronic kidney disease
Raouf M, Atkinson TJ, Crumb MW, Fudin J
Journal of Pain Research 2017, 10:275-278
Published Date: 27 January 2017
Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease
Mathew RO, Bettinger JJ, Wegrzyn EL, Fudin J
Journal of Pain Research 2016, 9:1191-1195
Published Date: 8 December 2016
Can we not work together to help family practitioners become more effective pain managers?
Fudin J, Atkinson TJ, Raouf M, Schatman ME
Journal of Pain Research 2016, 9:803-806
Published Date: 13 October 2016
OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form
Fudin J, Raouf M, Wegrzyn EL
Journal of Pain Research 2016, 9:609-612
Published Date: 7 September 2016
The MEDD myth: the impact of pseudoscience on pain research and prescribing-guideline development
Fudin J, Pratt Cleary J, Schatman ME
Journal of Pain Research 2016, 9:153-156
Published Date: 23 March 2016
In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysis
Linares OA, Schiesser WE, Fudin J, Pham TC, Bettinger JJ, Mathew RO, Daly AL
Journal of Pain Research 2015, 8:417-429
Published Date: 22 July 2015
The damage done by the war on opioids: the pendulum has swung too far
Atkinson TJ, Schatman ME, Fudin J
Journal of Pain Research 2014, 7:265-268
Published Date: 12 May 2014